Product NDC: | 13537-432 |
Proprietary Name: | CYZONE |
Non Proprietary Name: | Octinoxate and Oxybenzone |
Active Ingredient(s): | .07; .025 g/g; g/g & nbsp; Octinoxate and Oxybenzone |
Administration Route(s): | TOPICAL |
Dosage Form(s): | CREAM |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 13537-432 |
Labeler Name: | Ventura Corporation LTD. |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | part352 |
Marketing Category: | OTC MONOGRAPH FINAL |
Start Marketing Date: | 20120713 |
Package NDC: | 13537-432-01 |
Package Description: | 4 g in 1 TUBE, WITH APPLICATOR (13537-432-01) |
NDC Code | 13537-432-01 |
Proprietary Name | CYZONE |
Package Description | 4 g in 1 TUBE, WITH APPLICATOR (13537-432-01) |
Product NDC | 13537-432 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | Octinoxate and Oxybenzone |
Dosage Form Name | CREAM |
Route Name | TOPICAL |
Start Marketing Date | 20120713 |
Marketing Category Name | OTC MONOGRAPH FINAL |
Labeler Name | Ventura Corporation LTD. |
Substance Name | OCTINOXATE; OXYBENZONE |
Strength Number | .07; .025 |
Strength Unit | g/g; g/g |
Pharmaceutical Classes |